Published in Arch Dermatol Res on July 28, 1978
Lymphocyte proliferation during PUVA therapy. Arch Dermatol Res (1979) 0.86
Immunologic implications of PUVA therapy in psoriasis vulgaris. Arch Dermatol Res (1979) 0.84
PUVA treatment in chromium hypersensitivity: effect on skin reactivity and lymphocyte functions. Arch Dermatol Res (1981) 0.80
A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med (1970) 15.86
A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47
The human rosette-forming cell as a marker of a population of thymus-derived cells. J Clin Invest (1972) 4.80
Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med (1974) 4.38
Identification of two populations of immunoglobulin-bearing lymphocytes in man. J Immunol (1975) 3.83
Light-induced cross-linking of DNA in the presence of a furocoumarin (psoralen). Studies with phage lambda, Escherichia coli, and mouse leukemia cells. Biochim Biophys Acta (1970) 3.02
Studies of surface immunoglobulins on human B lymphocytes. I. Dissociation of cell-bound immunoglobulins with acid pH or at 37 degrees C. J Immunol (1975) 2.77
Penetration of epidermis by ultraviolet rays. Photochem Photobiol (1966) 1.90
Identification, enumeration, and isolation of B and T lymphocytes from human peripheral blood. Report of a WHO-IARC-sponsored workshop on human B and T cells, London, 15-17 July 1974. Scand J Immunol (1974) 1.53
Blood flow in cutaneous tissue in man studied by washout of radioactive xenon. Circ Res (1969) 1.51
Thymus-derived rosette-forming cells. N Engl J Med (1973) 1.50
Immunological aspects of psoriasis. II. Dissociated impairment of thymus-dependent lymphocytes. Br J Dermatol (1976) 1.44
Photoreactions at 3655 Angstrom between pyrimidine bases and skin-photosensitizing furocoumarins. Photochem Photobiol (1967) 1.34
Treatment of psoriasis with oral psoralens and longwave ultraviolet light. Therapeutic results and cytogenetic hazards. Acta Derm Venereol (1975) 1.34
Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer (1976) 1.33
Photosensitization of skin in vivo by furocoumarins (psoralens). Biochim Biophys Acta (1969) 1.29
Membrane-associated immunoglobulin determinants on bone marrow and blood lymphocytes in the pediatric age group and on fetal tissues. Ann N Y Acad Sci (1975) 1.24
Immunological responses of patients with psoriasis and the effect of treatment with methotrexate. Br J Dermatol (1975) 1.06
UVA-induced inhibition of proliferation of PHA-stimulated lymphocytes from humans treated with 8-methoxypsoralen. Br J Dermatol (1977) 1.04
Photochemotherapy of vitiligo. Use of orally administered psoralens and a high-intensity long-wave ultraviolet light system. Arch Dermatol (1976) 1.04
Psoralen plus near ultraviolet light inactivation of cultured Chinese hamster cells and its relation to DNA cross-links. Mutat Res (1973) 1.02
8-methoxypsoralen and UVA promote sister-chromatid exchanges. J Invest Dermatol (1976) 0.92
Toxic effects of 8-methoxypsoralen on lymphocyte division. Arch Dermatol Res (1977) 0.92
Photochemotherapy of mycosis fungoides: Preliminary communication. Dan Med Bull (1977) 0.91
T-lymphocytes and psoriasis. Arch Dermatol Res (1976) 0.91
Decreased circulating E rosette forming cells in psoralen UVA treated patients. Arch Dermatol Res (1977) 0.83
Clinical aspects of T and B lymphocytes in psoriasis. Arch Dermatol Res (1977) 0.81
Distribution of erythrocyte receptors at the surface membrane of human T-lymphocytes. Biomedicine (1976) 0.79
[Cellular immunity in psoriasis]. Ann Dermatol Syphiligr (Paris) (1976) 0.77
Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol (1991) 3.29
Chronic anal ulceration due to nicorandil. Br J Dermatol (2004) 3.18
Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol (1998) 2.20
Reactivity pattern of a monoclonal antikeratin antibody (KL1). J Invest Dermatol (1983) 1.98
Integrin beta 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet (1995) 1.90
Experimental production of antibodies against stratum corneum keratin polypeptides. Arch Dermatol Res (1980) 1.87
Rab27a: A key to melanosome transport in human melanocytes. J Cell Biol (2001) 1.86
Television-viewing habits and sleep disturbance in school children. Pediatrics (1999) 1.77
The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study. Br J Dermatol (2001) 1.75
Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J (2000) 1.73
Roaccutane treatment guidelines: results of an international survey. Dermatology (1997) 1.70
Attempt to protect rabbits against experimental syphilis by passive immunization. Br J Vener Dis (1973) 1.68
What are melanocytes really doing all day long...? Exp Dermatol (2009) 1.65
Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the gamma 2 subunit of nicein/kalinin (LAMININ-5). Nat Genet (1994) 1.63
Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol Cell Biol (1998) 1.62
Porokeratosis and immunosuppression. Eur J Dermatol (1999) 1.62
Dominant dystrophic epidermolysis bullosa associated with pyloric stenosis and congenital absence of skin. Arch Dermatol (2001) 1.60
Giant oral aphthous ulcers induced by nicorandil. Br J Dermatol (1998) 1.58
Milia-like idiopathic calcinosis cutis. Pediatr Dermatol (2004) 1.57
Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product. J Cell Biol (1996) 1.57
Antikeratin antibodies in serum and synovial fluid show specificity for rheumatoid arthritis in a study of connective tissue diseases. Ann Rheum Dis (1985) 1.54
External anogenital lesions in organ transplant recipients. A clinicopathologic and virologic assessment. Arch Dermatol (1997) 1.53
Arthritis, collagenous colitis, and discoid lupus. Ann Intern Med (1994) 1.52
Antinuclear autoantibodies in Swiss mice thymectomized at birth. Nature (1967) 1.50
PUVA-induced repigmentation of vitiligo: scanning electron microscopy of hair follicles. J Invest Dermatol (1980) 1.46
Defective expression of plectin/HD1 in epidermolysis bullosa simplex with muscular dystrophy. J Clin Invest (1996) 1.45
[Extracutaneous manifestations of neutrophilic dermatosis]. Ann Dermatol Venereol (1996) 1.41
EMLA cream as a topical anesthetic for the repeated mechanical debridement of venous leg ulcers: a double-blind, placebo-controlled study. J Am Acad Dermatol (1999) 1.41
Inhibition of the mitogen-activated protein kinase pathway triggers B16 melanoma cell differentiation. J Biol Chem (1998) 1.40
Clinical picture: eyelid metastasis. Lancet (2001) 1.39
[Atypical clinical forms of bullous pemphigoid]. Ann Dermatol Venereol (1990) 1.39
[Prospective study of treatment of bullous pemphigoid by a class I topical corticosteroid]. Ann Dermatol Venereol (1999) 1.39
Malignant lymphoma and dermatitis herpetiformis. Dermatology (1994) 1.39
[Oral photochemotherapy in vitiligo (author's transl)]. Ann Dermatol Venereol (1979) 1.39
Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol (2008) 1.39
[Practical use of antiseptics in dermatology]. Ann Dermatol Venereol (1989) 1.38
Fibroblastic rheumatism: clinical, histological, immunohistological, ultrastructural and biochemical study of a case. Br J Dermatol (1993) 1.38
Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10. J Biol Chem (2000) 1.36
Transposable B2 SINE elements can provide mobile RNA polymerase II promoters. Nat Genet (2001) 1.35
Monoclonal antibody GB3, a new probe for the study of human basement membranes and hemidesmosomes. Exp Cell Res (1987) 1.34
Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells. J Biol Chem (1995) 1.27
Inhibition of the phosphatidylinositol 3-kinase/p70(S6)-kinase pathway induces B16 melanoma cell differentiation. J Biol Chem (1996) 1.27
Immunohistochemical study of CD34-positive dendritic cells of human dermis. Am J Dermatopathol (1996) 1.25
Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa. Lab Invest (1991) 1.23
Hepatitis associated antigen and periarteritis nodosa (PAN). Vox Sang (1971) 1.23
Developmental expression of nicein adhesion protein (laminin-5) subunits suggests multiple morphogenic roles. Cell Adhes Commun (1994) 1.20
Congenital constriction band of the trunk. Pediatr Dermatol (1998) 1.19
The short arm of the laminin gamma2 chain plays a pivotal role in the incorporation of laminin 5 into the extracellular matrix and in cell adhesion. J Cell Biol (2001) 1.19
Ultraviolet B radiation acts through the nitric oxide and cGMP signal transduction pathway to stimulate melanogenesis in human melanocytes. J Biol Chem (1996) 1.18
Keratin polypeptides distribution in normal and diseased human epidermis and oral mucosa. Immunohistochemical study on unaltered epithelium and inflammatory, premalignant and malignant lesions. Virchows Arch A Pathol Anat Histol (1980) 1.18
Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life. Br J Dermatol (2005) 1.18
The 100-kDa chain of nicein/kalinin is a laminin B2 chain variant. Eur J Biochem (1994) 1.17
A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa. Hum Mol Genet (1995) 1.17
Inhibition of Rho is required for cAMP-induced melanoma cell differentiation. Mol Biol Cell (1998) 1.15
Investigation of a specific IgM antibody test in neonatal congenital syphilis. Br J Vener Dis (1970) 1.14
Lectins as markers of human epidermal cell differentiation. Differentiation (1982) 1.12
Specific immunity in patients suffering from recurring warts before and after repetitive intradermal tests with human papilloma virus. Br J Dermatol (1977) 1.11
PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes. Cell Death Differ (2004) 1.11
Diagnostic and neural analysis of skin cancer (DANAOS). A multicentre study for collection and computer-aided analysis of data from pigmented skin lesions using digital dermoscopy. Br J Dermatol (2003) 1.09
[Immunofluorescence studies of serum autoantibodies with respect to the constituents of the epidermis of burned patients]. Experientia (1968) 1.09
Interleukin-6 in normal skin and psoriasis. Acta Derm Venereol (1992) 1.09
Further diseases manifesting a uniform vascular response to different aetiological factors. Histopathology (1985) 1.08
Progressive replacement of human cultured epithelial allografts by recipient cells as evidenced by HLA class I antigens expression. Dermatologica (1987) 1.08
[Treatment of scleroderma]. Ann Med Interne (Paris) (1983) 1.07
Congenital self-healing histiocytosis (Hashimoto-Pritzker). An ultrastructural and immunohistochemical study. Cancer (1988) 1.07
Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia. Gene Ther (1998) 1.07
The atrophic variant of dermatofibrosarcoma protuberans in childhood: a report of six cases. Br J Dermatol (1998) 1.06
A study of nineteen immunocompromised patients with extensive skin lesions caused by Pseudomonas aeruginosa with and without bacteremia. Acta Derm Venereol (1991) 1.06
Lack of hypocomplementemia in chronic urticaria. Arch Dermatol (2000) 1.06
Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration. J Invest Dermatol (1983) 1.06
Aeromonas hydrophila with plasmid-borne class A extended-spectrum β-lactamase TEM-24 and three chromosomal class B, C, and D β-lactamases, isolated from a patient with necrotizing fasciitis. Antimicrob Agents Chemother (2004) 1.05
Precocious appearance of involucrin and epidermal transglutaminase during differentiation of psoriatic skin. Br J Dermatol (1986) 1.05
Expression of the CD34 antigen distinguishes Kaposi's sarcoma from pseudo-Kaposi's sarcoma (acroangiodermatitis). Br J Dermatol (1996) 1.04
Cloning and complete primary structure of the mouse laminin alpha 3 chain. Distinct expression pattern of the laminin alpha 3A and alpha 3B chain isoforms. J Biol Chem (1995) 1.04
The majority of epidermal Merkel cells are non-proliferative: a quantitative immunofluorescence analysis. Acta Derm Venereol (1987) 1.03
The safety of hydroquinone. J Eur Acad Dermatol Venereol (2006) 1.02
A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Acta Derm Venereol (2002) 1.01
Nitric oxide produced by ultraviolet-irradiated keratinocytes stimulates melanogenesis. J Clin Invest (1997) 1.01
Oral photochemotherapy in the treatment of lichen planus (LP). Clinical results, histological and ultrastructural observations. Br J Dermatol (1978) 1.00
[Scleroderma en coup de sabre with homolateral chronic glaucoma (author's transl)]. Ann Dermatol Venereol (1977) 1.00
Evaluation of cutaneous photodamage using a photographic scale. Br J Dermatol (1994) 1.00
Immunocytochemical evidence for a possible role of cross-linked keratinocyte envelopes in stratum corneum cohesion. J Histochem Cytochem (1991) 1.00
An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes. Br J Dermatol (2013) 0.99
PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study. Br J Dermatol (1979) 0.99
Psoriasis: an epidemiological evaluation of disease burden in 590 patients. J Eur Acad Dermatol Venereol (2010) 0.99
Expression of the hair stem cell-specific keratin 15 in pilar tumors of the skin. Eur J Dermatol (1999) 0.99
[Australia antigen, virus hepatitis and periarteritis nodosa]. Presse Med (1970) 0.99
Treatment of erosive oral lichen planus by the 308 nm excimer laser. Lasers Surg Med (2004) 0.99
Anatomical mapping of Merkel cells in normal human adult epidermis. Br J Dermatol (1991) 0.98
Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol (1995) 0.98
Differential expression of the CD10 antigen (neutral endopeptidase) in primary versus metastatic malignant melanomas of the skin. Melanoma Res (2002) 0.98
Cutaneous leukocytoclastic vasculitis and renal cancer: two cases. Am J Med (1993) 0.98